Society of Gynecologic Oncologists

🤖

AI Overview

With $490K in lobbying spend across 18 quarterly filings, Society of Gynecologic Oncologists is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2022.

$490K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$120K
2019	$120K
2020	$120K
2021	$90K
2022	$40K

Issues Lobbied

Medicare/Medicaid Defense Health Issues

Lobbying Firms

Galileo Consulting Group, INC.

Lobbyists

Jill Rathbun

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Defense, Health Issues

•-- H.R. 1892 - Continuing Resolution: Changes to the Medicare Access and CHIP Reauthorization Act of 2016 regarding CMS flexibility for cost measures, penalties, Part B drugs, and PTAC

•-- H.R. 3219 - Make America Secure Appropriations Act, 2018; H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018: FY 2018 funding for ovarian cancer research program at the Department of Defe

•-- H.R. 6157 / S. 3159 - Department of Defense Appropriations Act, 2019: FY 2019 funding for ovarian cancer research program at the Department of Defense

•-- House Subcommittee Draft / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019: FY 2019 federal research funding for gynecologic

•-- H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019; S.3159 - Department of Defense Appropriations